You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search


( ay-za-SYE-ti-deen )
New Drug Funding Program
  • Azacitidine - Acute Myeloid Leukemia (AML)
  • Azacitidine - Intermediate-2 and high-risk myelodysplastic syndrome (MDS)
Other Name(s): Vidaza® (Celgene)
Appearance: White, milky suspension for injection

You might also be interested in